WEKO3
アイテム
{"_buckets": {"deposit": "f5a4b3e4-9e0f-4b9c-84ad-2d3166abc93c"}, "_deposit": {"created_by": 2, "id": "20446", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "20446"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00020446", "sets": ["9"]}, "author_link": ["86432", "86435", "86434", "86433"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2008-06-15", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "1800", "bibliographicPageStart": "1796", "bibliographicVolumeNumber": "101", "bibliographic_titles": [{"bibliographic_title": "The American Journal of Cardiology"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The influence of obstructive sleep apnea syndrome (OSAS) on left ventricular function remains controversial. We examined the influence of OSAS on global left ventricular function using the myocardial performance index (Tei index) and plasma brain natriuretic peptide (BNP) level and investigated the effect of nasal continuous positive airway pressure (nCPAP) on these parameters. We obtained echocardiographic indexes including the Tei index and BNP concentrations from 27 patients with OSAS whose mean apnea--hypopnea index was 42.2 ± 21.5 events/hour and who were undergoing nCPAP and from 22 control subjects. We defined global left ventricular dysfunction (GLVD) as a Tei index ?0.50 and high BNP as ?20 pg/ml. Compared with controls, the Tei index of patients with OSAS was significantly increased (p \u003c0.01) and prevalence of GLVD was high (19%, p \u003c0.05). The correlation between the Tei index and apnea--hypopnea index was significant (r = 0.447, p \u003c0.05). Although BNP levels were higher in patients with OSAS than in controls, the difference did not reach significance. BNP level was high in 37% of patients with OSAS and in only 9% of controls (p \u003c0.05). The Tei index of patients with OSAS was significantly decreased after 1 month and 3 months of nCPAP (p \u003c0.01), and prevalence of GLVD significantly decreased from 19% to 4% (p \u003c0.05). In contrast, BNP significantly decreased at 3 months after nCPAP (p \u003c0.05). In conclusion, patients with moderate to severe OSAS frequently have impaired global left ventricular myocardial performance, which can be reversed at the early stage after starting nCPAP.", "subitem_description_type": "Abstract"}]}, "item_2_description_5": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "Without Tables", "subitem_description_type": "Other"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "The American Journal of Cardiology, 101(12), pp.1796-1800; 2008", "subitem_description_type": "Other"}]}, "item_2_relation_11": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "18549862", "subitem_relation_type_select": "PMID"}}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1016/j.amjcard.2008.02.083", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Copyright (c) 2008 Elsevier Inc. All rights reserved."}]}, "item_2_source_id_10": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00048410", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00029149", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Koga, Seiji"}], "nameIdentifiers": [{"nameIdentifier": "86432", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ikeda, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "86433", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Urata, Jungo"}], "nameIdentifiers": [{"nameIdentifier": "86434", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kohno, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "86435", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "AJC101_1796-Figure.pdf", "filesize": [{"value": "165.1 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 165100.0, "url": {"label": "AJC101_1796-Figure.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/20446/files/AJC101_1796-Figure.pdf"}, "version_id": "47b6d616-28f3-4e52-a33e-7ce72f771bff"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 1, "filename": "AJC101_1796.pdf", "filesize": [{"value": "141.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 141300.0, "url": {"label": "AJC101_1796.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/20446/files/AJC101_1796.pdf"}, "version_id": "967d74e6-9b8c-446a-b627-f265e3435886"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "sleep apnea", "subitem_subject_scheme": "Other"}, {"subitem_subject": "echocardiography", "subitem_subject_scheme": "Other"}, {"subitem_subject": "natriuretic peptide", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/16401", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-04-10"}, "publish_date": "2008-04-10", "publish_status": "0", "recid": "20446", "relation": {}, "relation_version_is_last": true, "title": ["Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome"], "weko_shared_id": -1}
Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome
http://hdl.handle.net/10069/16401
http://hdl.handle.net/10069/164011271d944-1874-4146-8abd-6745040a2395
名前 / ファイル | ライセンス | アクション |
---|---|---|
AJC101_1796-Figure.pdf (165.1 kB)
|
|
|
AJC101_1796.pdf (141.3 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-04-10 | |||||
タイトル | ||||||
タイトル | Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | sleep apnea | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | echocardiography | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | natriuretic peptide | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Koga, Seiji
× Koga, Seiji× Ikeda, Satoshi× Urata, Jungo× Kohno, Shigeru |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The influence of obstructive sleep apnea syndrome (OSAS) on left ventricular function remains controversial. We examined the influence of OSAS on global left ventricular function using the myocardial performance index (Tei index) and plasma brain natriuretic peptide (BNP) level and investigated the effect of nasal continuous positive airway pressure (nCPAP) on these parameters. We obtained echocardiographic indexes including the Tei index and BNP concentrations from 27 patients with OSAS whose mean apnea--hypopnea index was 42.2 ± 21.5 events/hour and who were undergoing nCPAP and from 22 control subjects. We defined global left ventricular dysfunction (GLVD) as a Tei index ?0.50 and high BNP as ?20 pg/ml. Compared with controls, the Tei index of patients with OSAS was significantly increased (p <0.01) and prevalence of GLVD was high (19%, p <0.05). The correlation between the Tei index and apnea--hypopnea index was significant (r = 0.447, p <0.05). Although BNP levels were higher in patients with OSAS than in controls, the difference did not reach significance. BNP level was high in 37% of patients with OSAS and in only 9% of controls (p <0.05). The Tei index of patients with OSAS was significantly decreased after 1 month and 3 months of nCPAP (p <0.01), and prevalence of GLVD significantly decreased from 19% to 4% (p <0.05). In contrast, BNP significantly decreased at 3 months after nCPAP (p <0.05). In conclusion, patients with moderate to severe OSAS frequently have impaired global left ventricular myocardial performance, which can be reversed at the early stage after starting nCPAP. | |||||
内容記述 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Without Tables | |||||
書誌情報 |
The American Journal of Cardiology 巻 101, 号 12, p. 1796-1800, 発行日 2008-06-15 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00029149 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00048410 | |||||
PubMed番号 | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | PMID | |||||
関連識別子 | 18549862 | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.amjcard.2008.02.083 | |||||
権利 | ||||||
権利情報 | Copyright (c) 2008 Elsevier Inc. All rights reserved. | |||||
著者版フラグ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | The American Journal of Cardiology, 101(12), pp.1796-1800; 2008 |